Chemoinformaics analysis of 6,7,8,9-Tetrahydro-5H-cyclohepta[b]pyridine
| Molecular Weight | 147.221 | nRot | 0 |
| Heavy Atom Molecular Weight | 134.117 | nRig | 27 |
| Exact Molecular Weight | 147.105 | nRing | 2 |
| Solubility: LogS | -4.685 | nHRing | 1 |
| Solubility: LogP | 4.861 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 26.4683 |
| nHD | 0 | BPOL | 14.1817 |
| QED | 0.291 |
| Synth | 2.756 |
| Natural Product Likeliness | -0.162 |
| NR-PPAR-gamma | 0.768 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.969 |
| Pgp-sub | 0.033 |
| HIA | 0.706 |
| CACO-2 | -5 |
| MDCK | 0.000133685 |
| BBB | 0.105 |
| PPB | 1.01714 |
| VDSS | 0.473 |
| FU | 0.0062187 |
| CYP1A2-inh | 0.328 |
| CYP1A2-sub | 0.052 |
| CYP2c19-inh | 0.938 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.969 |
| CYP2c9-sub | 0.104 |
| CYP2d6-inh | 0.46 |
| CYP2d6-sub | 0.34 |
| CYP3a4-inh | 0.951 |
| CYP3a4-sub | 0.344 |
| CL | 3.196 |
| T12 | 0.586 |
| hERG | 0.808 |
| Ames | 0.124 |
| ROA | 0.015 |
| SkinSen | 0.36 |
| Carcinogencity | 0.596 |
| EI | 0.009 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.055 |
| Antiviral | No |
| Prediction | 0.89805 |